VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 113 filers reported holding VERONA PHARMA PLC in Q1 2024. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $294 | -8.7% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q1 2024 | $322 | -22.4% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $415 | +29.7% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $320 | -20.8% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $404 | +6.3% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $380 | -24.6% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $504 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 901,943 | $3,716,000 | 2.47% |
| venBio Partners LLC | 456,770 | $1,882,000 | 1.60% |
| Aisling Capital Management LP | 443,596 | $1,828,000 | 0.80% |
| Vivo Capital, LLC | 1,492,951 | $6,151,000 | 0.56% |
| NEA Management Company, LLC | 1,219,674 | $5,025,000 | 0.26% |
| Novo Holdings A/S | 740,740 | $3,052,000 | 0.20% |
| Orbimed Advisors | 1,250,396 | $5,152,000 | 0.09% |
| Clear Creek Financial Management, LLC | 37,500 | $170,000 | 0.06% |
| Tekla Capital Management LLC | 253,179 | $1,043,000 | 0.05% |
| WEDBUSH SECURITIES INC | 70,950 | $292,000 | 0.04% |